BATS BZX Real-Time Price
As of 10:02am ET
| -0.03 / -0.85%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +42.45% increase from the last price of 3.51.
The current consensus among 4 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.